Cerebrovascular Disorders Clinical Trial
Official title:
The Manifestation of Surface EMG of Swallowing Muscles in Stroke Patients With Respiratory Muscle Training. A Prospective Study.
NCT number | NCT03767998 |
Other study ID # | CMRPG8F0961 |
Secondary ID | |
Status | Completed |
Phase | N/A |
First received | |
Last updated | |
Start date | May 1, 2017 |
Est. completion date | June 30, 2019 |
Verified date | November 2020 |
Source | Chang Gung Memorial Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
Purpose: To investigate of the respiratory function and swallowing function after respiratory muscle training, and the manifestation of surface EMG of swallowing muscles, and the lateralization of placement of electrodes in stroke patients. Methods: A prospective study. Consecutive patients with diagnosis of stroke will be proved by magnetic resonance image or computerized tomography. Stroke patients, aged 35-80 years old, with inspiratory muscle weakness or swallowing disturbance will be enrolled and randomly divided into control group (usual rehabilitation alone) and experimental group (inspiratory muscle strengthening training (IMST) group for patients with inspiratory muscle weakness and expiratory muscle strengthening training (EMST) for patients with swallowing disturbance, respectively. Each patients will receive usual rehabilitation. In the meanwhile we will recruit 23 healthy subjects for the control group. Each patient will receive baseline characteristics, duration of stroke, Brunnstrom's stage, muscle power, spirometry, peak cough flow, maximal inspiratory pressure (MIP),maximal expiratory pressure (MEP), resting heart rate, perception of dyspnea, resting oxyhemoglobin saturation (SpO2), hand grip strength of unaffected upper limb. And patients with swallowing disturbance will receive swallowing screen test, Functional Oral Intake Scale to evaluate the functional level of oral intake of food and liquid, and voice quality analysis for voice quality and bilateral surface electromyography for measurement of masseter, oris orbicularis, submental muscle and infraspinatus muscles. All of patients will be assessed again at 6 weeks and 12 weeks later. Patient with respiratory muscle weakness will receive IMT from 30% to 60 % of MIP through a respiratory trainer for two sets of 30 breaths or 6 sets of 10 repetitions. For patients with swallowing disturbance, EMST will commence from 15% to 75% of threshold load of an individual's MEP, 5 sets, 5 repetition with one minute of rest between sets.. The training resistance will be adjusted accordingly, with one or two minute of rest between sets. Both group will receive respiratory training, twice per day, 5 days per week. For checking the compliance of RMT at home, patients will be monitored by making a phone call to them once a week.
Status | Completed |
Enrollment | 46 |
Est. completion date | June 30, 2019 |
Est. primary completion date | October 31, 2018 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 35 Years to 80 Years |
Eligibility | Inclusion Criteria: - Patients identified as stroke, - Diagnosed by magnetic resonance image or computerized tomography - Capable of performing voluntary respiratory maneuvers Exclusion Criteria: - Increased intracranial pressure - Uncontrolled hypertension - Complicated arrhythmia - Decompensated heart failure - Unstable angina - Myocardial infarction in the preceding 3 months - Pneumothorax - Bullae/blebs - Severe cognitive function - Emotional disturbance - Infection |
Country | Name | City | State |
---|---|---|---|
Taiwan | Department of Physical Medicine and Rehabilitation, Kaohsiung Chang Gung Memorial Hospital. | Kaohsiung |
Lead Sponsor | Collaborator |
---|---|
Chang Gung Memorial Hospital |
Taiwan,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Primary | MIP (maximal inspiratory pressure) | MIP(cm H20) is measured after maximal expiration while patients sitting and wearing a nose-clip. For MIP, more negative pressure is better. | At the beginning and the end of program respectively, up to 6 weeks. | |
Primary | MEP (maximal expiratory pressure) | MEP(cm H20) is measured after maximal inspiration while patients sitting and wearing a nose-clip. For MEP, more positive is better. | At the beginning and the end of program respectively, up to 6 weeks. | |
Primary | Surface EMG data | The EMG of masseter, orbicularis oris, submental (anterior belly of digastrics, mylohyoid, geniohyoid) and infrahyoid muscles will be recorded. Three trials of dry swallowing, voluntary water swallowing, and breathing through a breathing trainer in low intensity and about 50% of the measured intensity of maximal expiratory pressure at beginning of program will be recorded | At the beginning and the end of program respectively, up to 6 weeks. | |
Secondary | Forced vital capacity, FVC(liter) | Pulmonary functional test, the determination of the vital capacity from a maximally forced expiratory effort. | At the beginning and the end of program respectively, up to 6 weeks. | |
Secondary | Forced vital capacity, FVC(%pred)(liter) | Pulmonary functional test, the determination of the vital capacity from a maximally forced expiratory effort. | At the beginning and the end of program respectively, up to 6 weeks. | |
Secondary | Forced expiratory volume 1/Forced vital capacity, FEV1/FVC(%) | Pulmonary functional test, a calculated ratio used in the diagnosis of obstructive and restrictive lung disease. | At the beginning and the end of program respectively, up to 6 weeks. | |
Secondary | Maximal mid-expiratory flow, MMEF(%) | Pulmonary functional test, the peak of expiratory flow as taken from the flow-volume curve and measured in liters per second. | At the beginning and the end of program respectively, up to 6 weeks. | |
Secondary | Peak cough flow(liter/min) | Maximum speed of expiration. | At the beginning and the end of program respectively, up to 6 weeks. | |
Secondary | Resting heart rate | Heart rate of patient during resting. | At the beginning and the end of program respectively, up to 6 weeks. | |
Secondary | Resting respiratory rate | Respiratory rate of patient during resting. | At the beginning and the end of program respectively, up to 6 weeks. | |
Secondary | Functional Oral Intake Scale | Level 1: Nothing by mouth. Level 2: Tube dependent with minimal attempts of food or liquid. Level 3: Tube dependent with consistent oral intake of food or liquid. Level 4: Total oral diet of a single consistency. Level 5: Total oral diet with multiple consistencies, but requiring special preparation or compensations.Level 6: Total oral diet with multiple consistencies without special preparation, but with specific food limitations. Level 7: Total oral diet with no restrictions. Level 1 to level 7. | At the beginning and the end of program respectively, up to 6 weeks. | |
Secondary | Borg's Scale | Modified Borg scale (0.5 to 10) 0 Nothing at all 0.5 Very, very slight (just noticeable)
Very slight Slight Moderate Somewhat severe Severe 7 Very severe 8 9 Very, very severe (almost maximal) 10 Maximal |
At the beginning and the end of program respectively, up to 6 weeks. | |
Secondary | Fatigue Assessment Scale | Score: 5-50. 1 = Never, 2 = Sometimes; 3 = Regularly; 4 = Often and 5 = Always. 10 items. | At the beginning and the end of program respectively, up to 6 weeks. |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT03239847 -
Cost Effectiveness of the EndoPhys Pressure Sensing Access System vs. Radial A-line for Intra-operative Blood Pressure Monitoring
|
N/A | |
Recruiting |
NCT03544801 -
Renji Cerebral Small Vessel Disease Corhort Study
|
||
Recruiting |
NCT06010823 -
Safety and Efficacy Evaluation of the Robotic Enhanced Error Training of Upper Limb Function in Post-stroke and Post TBI Participants
|
N/A | |
Withdrawn |
NCT04991038 -
Clinical Investigation to Compare Safety and Efficacy of DAISE and Stent Retrievers for Thrombectomy In Acute Ischemic Stroke Patients
|
N/A | |
Recruiting |
NCT02472028 -
Blood Pressure Reduction to Limit the Evolution of Vascular Brain Lesions in Elderly Individuals
|
Phase 4 | |
Completed |
NCT01915368 -
Determining Optimal Post-Stroke Exercise (DOSE)
|
N/A | |
Active, not recruiting |
NCT01555411 -
Akershus Cardiac Examination (ACE) 1950 Study
|
||
Completed |
NCT01304576 -
Orientation Agnosia: Clinical and Anatomical Study
|
N/A | |
Completed |
NCT00049894 -
Predictors of Recurrent Stroke in the PROGRESS Study
|
N/A | |
Completed |
NCT00059293 -
Transcranial Doppler (TCD) Ultrasound of Subjects Enrolled in BABY HUG - Ancillary to BABY HUG
|
||
Completed |
NCT00049920 -
The ARIC MRI Study
|
N/A | |
Completed |
NCT00005562 -
Coronary Artery Calcium, Exercise Tests, and CHD Outcome
|
N/A | |
Completed |
NCT00005395 -
Honolulu Heart Program-Study of Stroke and Dementia
|
N/A | |
Completed |
NCT00000479 -
Women's Health Study (WHS): A Randomized Trial of Low-dose Aspirin and Vitamin E in the Primary Prevention of Cardiovascular Disease and Cancer
|
Phase 3 | |
Completed |
NCT00005140 -
Epidemiology of Cardiovascular and Non-Cardiovascular Risk In Chicago
|
N/A | |
Enrolling by invitation |
NCT00005485 -
The Jackson Heart Study of Cardiovascular Disease Among African Americans
|
||
Recruiting |
NCT06275113 -
BRING-UP Prevention
|
||
Completed |
NCT02702635 -
Measuring Blood Flow Characteristics Using Dynamic Contrast Enhanced Magnetic Resonance Imaging
|
N/A | |
Recruiting |
NCT04336852 -
Development of a Clinically-relevant Test for Assessment of Cerebral Vascular Function
|
N/A | |
Not yet recruiting |
NCT05892510 -
Post-thrombectomy Intra-arterial Tenecteplase for Acute manaGement of Non-retrievable Thrombus and No-reflow in Emergent Stroke
|
Phase 2/Phase 3 |